| 1 |
[GO] |
2025―Feb―13 |
Generation of SARS-CoV-2 dual-target candidate inhibitors through 3D equivariant conditional generative neural networks |
Zhong-Xing Zhou, Hong-Xing Zhang, Qingchuan Zheng |
| 2 |
[GO] |
2025―Feb―08 |
Uncovering the covalent inhibitors of SARS-CoV-2 Mpro in Tibetan edible herb Rhodiola crenulata and their synergistic anti-Mpro mechanism |
Guang-Hao Zhu, Ya-Ni Zhang, Yuan Xiong, Xu-Dong Hou, Qing-Guang Zhang, Zhao-Qin Zhang, et al. (+3) Xiao-Yu Zhuang, Wei-Dong Zhang, Guang-Bo Ge |
| 3 |
[GO] |
2023―Aug―12 |
Optimization of Nucleic Acid Extraction Methods for Rapid Detection In Pandemic Situations Or Diseases With High Prevalence |
Hesti Lina Wiraswati, Ilma Fauziah Ma’ruf, Savira Ekawardhani, Lia Faridah, Amila Laelalugina, Harry Septanto, et al. (+3) Imam Damar Djati, Shabarni Gaffar, Asif Awaludin |
| 4 |
[GO] |
2023―Mai―22 |
Licorice-saponin A3 is a broad-spectrum inhibitor for COVID-19 by targeting viral spike and anti-inflammation |
Yang Yi, Wenzhe Li, Kefang Liu, Heng Xue, Rong Yu, Meng Zhang, et al. (+15) Yang-Oujie Bao, Xinyuan Lai, Jingjing Fan, Yuxi Huang, Jing Wang, Xiaomeng Shi, Junhua Li, Hongping Wei, Kuanhui Xiang, Linjie Li, Rong Zhang, Xin Zhao, Xue Qiao, Hang Yang, Min Ye |
| 5 |
[GO] |
2023―Apr―15 |
Dock-able linear and homodetic di, tri, tetra and pentapeptide library from canonical amino acids: SARS-CoV-2 Mpro as a case study |
Sarfraz Ahmad, Muhammad Usman Mirza, John.F. Trant |
| 6 |
[GO] |
2022―Dez―21 |
Corrigendum to “The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review” [J. Pharma. Anal. 11 (2021) 265-271] |
Leonny Dwi Rizkita, Indwiani Astuti |
| 7 |
[GO] |
2022―Nov―02 |
Advances And Challenges In Using Nirmatrelvir And Its Derivatives Against Sars-Cov-2 Infection |
Wujun Chen, Bing Liang, Xiaolin Wu, Ling Li, Chao Wang, Dongming Xing |
| 8 |
[GO] |
2022―Okt―27 |
Evaluation of immunoprotection against coronavirus disease 2019: Novel variants, vaccine inoculation, and complications |
Congshan Jiang, Kaichong Jiang, Xiaowei Li, Ning Zhang, Wenhua Zhu, Liesu Meng, et al. (+2) Yanmin Zhang, Shemin Lu |
| 9 |
[GO] |
2022―Okt―22 |
Inosine: a broad-spectrum anti-inflammatory against SARS-CoV-2 infection-induced acute lung injury via suppressing TBK1 phosphorylation |
Ningning Wang, Entao Li, Huifang Deng, Lanxin Yue, Lei Zhou, Rina Su, et al. (+6) Baokun He, Chengcai Lai, Gaofu Li, Yuwei Gao, Wei Zhou, Yue Gao |
| 10 |
[GO] |
2022―Jan―04 |
Machine learning empowered COVID-19 patient monitoring using non-contact sensing: An extensive review |
Umer Saeed, Syed Yaseen Shah, Jawad Ahmad, Muhammad Ali Imran, Qammer H. Abbasi, Syed Aziz Shah |
| 11 |
[GO] |
2021―Dez―17 |
Angiotensin-converting enzyme 2 as a potential therapeutic target for COVID-19: A review |
Bhagat Singh, Dheer Singh, Vinod Verma, Ramakant Yadav, Raj Kumar |
| 12 |
[GO] |
2021―Nov―10 |
An outlook on coronavirus disease 2019 detection methods |
Zahra Hassani Nejad, Fataneh Fatemi, Seyed Ehsan Ranaei Siadat |
| 13 |
[GO] |
2021―Sep―20 |
Antiviral, immunomodulatory, and anticoagulant effects of quercetin and its derivatives: Potential role in prevention and management of COVID-19 |
Souparnika H. Manjunath, Rajesh K. Thimmulappa |
| 14 |
[GO] |
2021―Sep―16 |
Assessment of the binding interactions of SARS-CoV-2 spike glycoprotein variants |
Deepa Raghu, Pamela Hamill, Arpitha Banaji, Amy McLaren, Yu-Ting Hsu |
| 15 |
[GO] |
2021―Sep―14 |
COVID-19 vaccine candidates and vaccine development platforms available worldwide |
Nilgun Duman, Zahraa ALzaidi, Busra Aynekin, Duygu Taskin, Busra Demirors, Abdulbaki Yildirim, et al. (+6) Izem Olcay Sahin, Faik Bilgili, Eda Tahir Turanli, Tommaso Beccari, Matteo Bertelli, Munis Dundar |
| 16 |
[GO] |
2021―Sep―04 |
Drug repurposing against coronavirus disease 2019 (COVID-19): A review |
Lianxiang Luo, Qin Qiu, Fangfang Huang, Kaifeng Liu, Yongqi Lan, Xiaoling Li, et al. (+3) Yuge Huang, Liao Cui, Hui Luo |
| 17 |
[GO] |
2021―Aug―05 |
Possible therapeutic targets and promising drugs based on unsymmetrical hetaryl-substituted porphyrins to combat SARS-CoV-2 |
Yury A. Gubarev, Natalya Sh Lebedeva, Elena S. Yurina, Sergey S. Syrbu, Aleksey N. Kiselev, Mikhail A. Lebedev |
| 18 |
[GO] |
2021―Jun―19 |
Covid-19 rhapsody: Rage towards advanced diagnostics and therapeutic strategy |
Koel Sinha, Sutapa Som Chaudhury, Pramita Sharma, Bhuban Ruidas |
| 19 |
[GO] |
2021―Apr―05 |
Reducing SARS-CoV-2 Pathological Protein Activity with Small Molecules |
Donata Pluskota-Karwatka, Marcin Hoffmann, Jan Barciszewski |
| 20 |
[GO] |
2021―Mrz―27 |
Molecular detection of SARS-CoV-2 being challenged by virus variation and asymptomatic infection |
Congshan Jiang, Xiaowei Li, Changrong Ge, Yuanyuan Ding, Tao Zhang, Shuai Cao, et al. (+2) Liesu Meng, Shemin Lu |
| 21 |
[GO] |
2021―Mrz―24 |
The potential of miRNA-based therapeutics in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection: a review |
Leonny Dwi Rizkita, Indwiani Astuti |
| 22 |
[GO] |
2021―Jan―30 |
Accurate and sensitive determination of hydroxychloroquine sulfate used on COVID-19 patients in human urine, serum and saliva samples by GC-MS |
Süleyman Bodur, Sezin Erarpat, Ömer Tahir Günkara, Sezgin Bakırdere |
| 23 |
[GO] |
2021―Jan―14 |
Current diagnostic and therapeutic strategies for COVID-19 |
Bin Bin Chen, Meng Li Liu, Cheng Zhi Huang |
| 24 |
[GO] |
2020―Sep―07 |
Potential Treatment of Chinese and Western Medicine Targeting Nsp14 of SARS-CoV-2 |
Chao Liu, Xiaoxiao Zhu, Yiyao Lu, Xianqin Zhang, Xu Jia, Tai Yang |
| 25 |
[GO] |
2020―Aug―28 |
Discovery of human coronaviruses pan-papain-like protease inhibitors using computational approaches |
Mubarak A. Alamri, Muhammad Tahir ul Qamar, Muhammad Usman Mirza, Safar M. Alqahtani, Matheus Froeyen, Ling-Ling Chen |
| 26 |
[GO] |
2020―Jun―26 |
Use of subcutaneous tocilizumab to prepare intravenous solutions for COVID-19 emergency shortage: Comparative analytical study of physicochemical quality attributes |
Natalia Navas, Jesús Hermosilla, Anabel Torrente-López, José Hernández, Jose Cabeza, Raquel Pérez-Robles, Antonio Salmerón-García |
| 27 |
[GO] |
2020―Apr―28 |
Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase |
Muhammad Usman Mirza, Matheus Froeyen |
| 28 |
[GO] |
2020―Mrz―26 |
Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants |
Muhammad Tahir ul Qamar, Safar M. Alqahtani, Mubarak A. Alamri, Ling-Ling Chen |
| 29 |
[GO] |
2020―Mrz―09 |
Molecular immune pathogenesis and diagnosis of COVID-19 |
Xiaowei Li, Manman Geng, Yizhao Peng, Liesu Meng, Shemin Lu |
| 30 |
[GO] |
2020―Mrz―06 |
Quantitative computed tomography analysis for stratifying the severity of Coronavirus Disease 2019 |
Cong Shen, Nan Yu, Shubo Cai, Jie Zhou, Jiexin Sheng, Kang Liu, et al. (+3) Heping Zhou, Youmin Guo, Gang Niu |
| 31 |
[GO] |
2020―Mrz―01 |
Recent advances and perspectives of nucleic acid detection for coronavirus |
Minzhe Shen, Yin Zhou, Jiawei Ye, Abdu Ahmed Abdullah AL-maskri, Yu Kang, Su Zeng, Sheng Cai |
